India-made drug to cure mild Covid in phase 1 trial 

Lagatar24 Desk An Indigenous Drug is likely to be available in the market which could cure mild COVID cases as it has shown potential to turn RT-PCR negative of the mildly infected persons within 72-90 hours. The drug is in phase 1 of Human trials and has shown the potential to be effective in mild … Continue reading India-made drug to cure mild Covid in phase 1 trial